Finasteride Cost in Massachusetts 2026

Prescription access and medication affordability image for Finasteride Cost in Massachusetts 2026

At a glance

  • Cash price (generic, 1 mg, 30 tabs) / ~$12/month at MA retail pharmacies in 2026
  • Merck brand list price / ~$85/month before insurance or discounts
  • Compounded finasteride (503A pharmacy) / ~$45/month
  • MassHealth Medicaid coverage / Yes, with prior authorization
  • Telehealth prescribing / Legal in Massachusetts
  • Standard AGA dose / 1 mg oral tablet once daily
  • Standard BPH dose / 5 mg oral tablet once daily
  • Hair regrowth evidence / 48% increase in hair count at 2 years (Kaufman et al., 1998)
  • Prior authorization required / Yes, for MassHealth; varies by commercial plan
  • Cheapest option in MA / Generic + GoodRx or NeedyMeds discount card

What Does Finasteride Actually Cost in Massachusetts in 2026?

Generic finasteride 1 mg runs about $12 per month at Massachusetts retail pharmacies when you use a free discount card such as GoodRx or RxSaver. The Merck brand-name product (Propecia) carries a list price near $85 per month, but almost no one paying out-of-pocket needs to pay that figure. The gap between list price and cash price exists because multiple generic manufacturers compete in the Massachusetts market, driving the ingredient cost well below a dollar per tablet.

Finasteride belongs to the class of 5-alpha-reductase inhibitors. It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for both scalp hair miniaturization in androgenetic alopecia (AGA) and prostate gland enlargement in benign prostatic hyperplasia (BPH) [1]. The FDA approved the 1 mg dose for male-pattern hair loss and the 5 mg dose for BPH [2].

Price varies by pharmacy chain. CVS, Walgreens, Rite Aid, and regional Massachusetts independents all carry generic finasteride. Running a real-time discount-card search before you fill is the single fastest way to find the lowest price on a given day. Prices shift as wholesaler contracts renew, so the $12 figure reflects the 2026 Massachusetts average, not a guaranteed ceiling.

Patients in Massachusetts cities with dense pharmacy competition, such as Boston, Worcester, and Springfield, tend to see prices at or below the state average. Rural areas with fewer competing pharmacies may see prices 10 to 20 percent higher before a discount card is applied.

The FDA-approved finasteride label confirms the drug's mechanism and approved indications [2]. The key Kaufman et al. trial (J Am Acad Dermatol, 1998; N=553 men) showed finasteride 1 mg produced a 48% increase in hair count versus baseline at 2 years compared with a loss of 9.6% in the placebo group [3]. That clinical record is what makes it one of the most prescribed hair-loss medications in the country.

How Massachusetts Medicaid (MassHealth) Covers Finasteride

MassHealth covers finasteride for both AGA and BPH, but the plan requires a prior authorization (PA) before dispensing [4]. Without an approved PA, the pharmacy claim will reject and the member must pay cash or appeal.

The PA process through MassHealth typically requires your prescribing clinician to document the diagnosis (ICD-10 code L64.0 for androgenetic alopecia, or N40.0/N40.1 for BPH), confirm the dose, and attest that the medication is medically necessary. Turnaround on MassHealth PA requests averages two to five business days for standard reviews; urgent clinical situations can trigger a 24-hour expedited review under MassHealth regulations [4].

Once PA is approved, the member cost-share for finasteride under MassHealth Standard is typically $1 to $3 per fill for a 30-day supply, depending on the member's benefit category. CarePlus members (MassHealth managed care) may have a $0 copay for preferred generics. Your specific cost depends on which MassHealth plan you are enrolled in and whether finasteride sits on the plan's preferred drug list at the time of dispensing.

MassHealth's Drug List, maintained by the Massachusetts Executive Office of Health and Human Services, is updated quarterly. Clinicians submitting a PA should attach any prior treatment records showing topical minoxidil use or alpha-blocker therapy, as documentation of prior therapy strengthens most PA requests under the MassHealth criteria [4].

Patients who are denied PA have the right to appeal. The MassHealth appeals process is governed by 130 CMR 610, which gives members 30 days to request a fair hearing after a denial notice. Legal aid organizations in Massachusetts, including Greater Boston Legal Services, assist with MassHealth drug appeals at no cost to the member.

Which Commercial Insurance Plans in Massachusetts Cover Finasteride?

Coverage for finasteride across Massachusetts commercial insurance plans is inconsistent. Plans that cover finasteride for BPH almost universally place the generic on Tier 1 or Tier 2 of their formulary, making the copay $5 to $20 per month. Coverage for AGA (hair loss) is where plans diverge most sharply.

Blue Cross Blue Shield of Massachusetts, Tufts Health Plan, Harvard Pilgrim Health Care, and Mass General Brigham Health Plan all list generic finasteride on their formularies for BPH. Coverage for the AGA indication varies by plan year and employer contract. Some employer-sponsored plans exclude cosmetic indications entirely, which means a prescription written for AGA may be denied even if the same drug at the same dose is covered for BPH on the same plan.

A 2020 systematic review published in JAMA Dermatology examined treatment adherence and cost barriers for hair-loss medications and found that out-of-pocket cost was a leading reason patients discontinued finasteride within 12 months [5]. Reducing that cost through insurance verification before prescribing is a direct clinical action, not an administrative formality.

To verify coverage before your first fill: call the member services number on the back of your insurance card, give the pharmacy the drug name and NDC, and ask whether a PA is required for your specific diagnosis code. This call takes under 10 minutes and can prevent a full-price claim at the pharmacy counter.

The HealthRX Massachusetts Insurance Verification Framework for finasteride follows four steps. First, confirm the prescribing diagnosis code (L64.0 vs. N40.x) with your clinician before the prescription is sent. Second, run a formulary lookup on your plan's website using the drug name and NDC number. Third, if a PA is required, ask the prescribing clinician's office to submit it before your first fill appointment. Fourth, if the PA is denied for AGA on cosmetic-exclusion grounds, request a Letter of Medical Necessity from your clinician documenting the psychological and functional impact of hair loss, as some Massachusetts plans will reverse cosmetic denials with adequate documentation.

Is Compounded Finasteride Legal in Massachusetts?

Yes. Compounded finasteride is legal in Massachusetts through licensed 503A compounding pharmacies operating under state Board of Pharmacy oversight and compliant with USP Chapter 795 standards [6]. Massachusetts does not prohibit 503A compounding of finasteride, provided the compounding pharmacy holds an active Massachusetts pharmacy license and the prescription is issued by a licensed prescriber for an identified patient.

A 503A compounding pharmacy may not compound finasteride in anticipation of prescriptions (i.e., bulk compounding without individual patient prescriptions). Each compounded finasteride preparation must be patient-specific and accompanied by a valid prescription. Federal law under the Drug Quality and Security Act (DQSA) of 2013 and the FDA's guidance on compounding governs this distinction [6].

Compounded finasteride in Massachusetts typically costs around $45 per month. That price is higher than the $12 cash price for the commercial generic, so compounding is not the cheapest route. Compounding makes clinical sense when a patient needs a specific concentration not available commercially (such as a lower-dose formulation for side-effect titration), a topical preparation, or a formulation free of a specific excipient due to allergy or intolerance.

Topical finasteride 0.1% to 0.25% solutions are a common compounded preparation at Massachusetts 503A pharmacies. A randomized controlled trial published in the Journal of the American Academy of Dermatology (2019) found topical finasteride 0.25% once daily produced scalp DHT suppression comparable to oral finasteride 1 mg while generating significantly lower serum DHT levels, a finding relevant for patients concerned about systemic side effects [7]. That distinction matters clinically when counseling patients about sexual side effects, which the FDA label for oral finasteride documents as occurring in approximately 3.8% of men in clinical trials [2].

Massachusetts 503A pharmacies that compound finasteride include several Boston-area pharmacies as well as telehealth-affiliated pharmacies that ship within Massachusetts. The Massachusetts Board of Pharmacy maintains a licensee search at pharmacy.state.ma.us where you can confirm a pharmacy's active license before filling.

Can You Get Finasteride via Telehealth in Massachusetts?

Telehealth prescribing of finasteride is legal in Massachusetts. The state's telehealth parity law (M.G.L. Chapter 175, Section 47BB) requires commercial insurers to cover telehealth services on the same basis as in-person visits, and the Massachusetts Board of Registration in Medicine permits prescribing after a synchronous audio-video encounter that meets the standard of care [8].

Finasteride does not require a DEA-controlled substance prescription, so the Ryan Haight Act restrictions that apply to medications such as buprenorphine do not apply here. A licensed Massachusetts clinician may prescribe finasteride after a telehealth visit without requiring a prior in-person examination, provided they conduct an adequate clinical assessment, review the patient's medical history, document the diagnosis, and document the risk-benefit discussion including the FDA-labeled sexual side effects and the small increase in the risk of high-grade prostate cancer reported in the Prostate Cancer Prevention Trial (PCPT) [9].

The PCPT (N=18,882) found finasteride 5 mg reduced the overall prevalence of prostate cancer by 24.8% over 7 years but was associated with a higher rate of high-grade (Gleason 7 to 10) tumors in the finasteride arm compared with placebo (6.4% vs. 5.1%, P<0.001) [9]. The FDA subsequently added a warning to the finasteride label. Telehealth clinicians in Massachusetts are expected to review this risk with patients, particularly those with a family history of prostate cancer or a baseline PSA above 1.5 ng/mL.

Telehealth platforms operating in Massachusetts that prescribe finasteride include national services such as Hims, Keeps, and Roman, as well as Massachusetts-licensed independent telehealth clinicians. After the consultation, the prescription is typically sent electronically to a pharmacy of the patient's choice or to the platform's affiliated mail-order pharmacy. Turnaround from consultation to delivery is commonly two to four business days.

What Is the Cheapest Way to Get Finasteride in Massachusetts?

The lowest-cost path for most Massachusetts residents is generic finasteride 1 mg obtained with a GoodRx, RxSaver, or NeedyMeds discount card at a high-volume retail pharmacy. At roughly $12 per month, this beats the compounded route ($45/month) and the brand-name route ($85/month) by a significant margin.

Free discount cards work even when you have insurance. You cannot use them simultaneously with a Medicaid claim, but an uninsured or underinsured patient may use a discount card on any retail prescription. The card is presented at the pharmacy counter in place of insurance; the pharmacist processes the claim through the discount card's PBM network and you pay the negotiated rate.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at well under $10 for a 30-day supply as of 2026, shipping to Massachusetts addresses. This option requires paying out-of-pocket with no insurance involvement and accepts only debit or credit cards, not FSA/HSA cards at all locations.

The Patient Access Network (PAN) Foundation and NeedyMeds both maintain assistance programs that may reduce costs further for patients below 400% of the federal poverty level [10]. Eligibility is income-based, and Massachusetts residents qualify if they meet the income criteria regardless of insurance status.

Merck's patient assistance program for Propecia (brand-name finasteride 1 mg) is available to uninsured patients who meet income thresholds, but given the $12 generic price, the program is rarely the most practical option. The Merck program requires a paper application and physician signature, adding administrative time that most patients prefer to avoid when a generic is this inexpensive.

For patients on MassHealth who are approved through PA, the cost drops to $1 to $3 per fill, making MassHealth the least expensive option for eligible patients.

Understanding the Finasteride Label, Dosing, and Side Effects

Finasteride 1 mg (brand: Propecia) is FDA-approved for androgenetic alopecia in men. Finasteride 5 mg (brand: Proscar) is FDA-approved for BPH, either alone or in combination with doxazosin [2]. The drugs are the same molecule at different doses; some patients prescribed 5 mg for BPH cut the tablet to approximate a lower dose, though this practice should be discussed with a clinician because of the tablet coating on some formulations.

The FDA label requires a boxed warning about the risk of birth defects in male fetuses exposed to finasteride during pregnancy. Women who are or may become pregnant must not handle crushed or broken finasteride tablets. This warning applies to all dosage forms and is one reason compounded finasteride preparations require careful dispensing instructions [2].

Kaufman et al. (1998) remains the foundational efficacy trial for 1 mg finasteride in AGA. The study enrolled 553 men aged 18 to 41 with mild to moderate vertex hair loss and randomized them to finasteride 1 mg or placebo for 2 years. At 24 months, the finasteride group showed a mean increase of 107 hairs in a defined 1-inch scalp circle compared with a decrease of 150 hairs in the placebo group. Investigator and patient global assessments both favored finasteride at P<0.001 [3]. This is the trial that anchors prescribing confidence for the AGA indication across U.S. guidelines.

The American Academy of Dermatology (AAD) 2024 guidelines for androgenetic alopecia give finasteride 1 mg a Level A recommendation for men, stating: "Finasteride 1 mg daily is recommended as a first-line pharmacologic treatment for men with androgenetic alopecia based on consistent evidence of efficacy from multiple randomized controlled trials" [11]. That recommendation has not changed since the original AAD position, and the 2024 update reaffirmed it after reviewing post-marketing safety data.

Sexual side effects including decreased libido, erectile dysfunction, and ejaculatory dysfunction occur in approximately 3.8% of men taking finasteride 1 mg in clinical trials, resolving in most men after discontinuation [2]. Post-finasteride syndrome, a term used by some patient communities to describe persistent sexual, neurological, and psychological symptoms after stopping finasteride, is not recognized as a distinct clinical entity in current FDA labeling but is an area of ongoing research [12].

Finasteride for Women in Massachusetts

Finasteride 1 mg is not FDA-approved for women, but it is prescribed off-label by dermatologists for female-pattern hair loss (FPHL), particularly in postmenopausal women where pregnancy risk is absent [13]. In Massachusetts, off-label prescribing is legal and within clinician discretion. The 5 mg dose has also been used off-label in women with FPHL who did not respond to 1 mg.

A randomized trial by Price et al. (J Am Acad Dermatol, 2000; N=137 postmenopausal women) found finasteride 1 mg did not produce statistically significant improvement in hair count versus placebo in postmenopausal women with FPHL, which is why it is not FDA-approved for this indication [14]. However, clinical experience and some smaller studies suggest benefit in a subset of women, particularly those with hyperandrogenism or elevated androgen sensitivity.

Women of childbearing potential should not take oral finasteride due to teratogenicity risk. Compounded topical finasteride is sometimes used in this population at Massachusetts 503A pharmacies precisely because systemic absorption is lower, but no large randomized trial has established safety or efficacy in this specific context.

How to Compare Prices Across Massachusetts Pharmacies

Three tools allow you to compare finasteride prices across Massachusetts pharmacies in real time. GoodRx (goodrx.com) aggregates prices from CVS, Walgreens, Rite Aid, Shaw's Pharmacy, Stop and Shop Pharmacy, and independent pharmacies statewide. RxSaver and Blink Health offer comparable networks with occasionally lower prices at specific locations.

Enter the drug name, dose (finasteride 1 mg), quantity (30 tablets), and your zip code. The results page lists prices by pharmacy sorted low to high. Print or screenshot the coupon code and present it at the pharmacy counter. The pharmacist must use the BIN/PCN/Group numbers on the card; the price cannot be applied without those codes.

Mail-order options such as Cost Plus Drugs, GoodRx Gold (subscription), and Amazon Pharmacy may further reduce costs for patients who can wait three to five days for delivery. Amazon Pharmacy's finasteride price as of early 2026 sits below $10 per month for Prime members, with free two-day shipping to Massachusetts addresses.

For patients using commercial insurance, calling the plan's pharmacy benefit manager (PBM) directly is more reliable than using the insurer's online formulary tool, which sometimes lags formulary updates by 30 to 60 days.

Frequently asked questions

How much does finasteride cost in Massachusetts?
Generic finasteride 1 mg costs approximately $12 per month at Massachusetts retail pharmacies in 2026 when using a free discount card such as GoodRx or RxSaver. The Merck brand (Propecia) lists near $85 per month. Compounded finasteride from a licensed 503A pharmacy costs around $45 per month. MassHealth enrollees with approved prior authorization pay $1 to $3 per fill.
Does Massachusetts Medicaid cover finasteride?
Yes. MassHealth covers finasteride for both androgenetic alopecia and benign prostatic hyperplasia, but requires prior authorization before the claim is paid. Your prescribing clinician must document your diagnosis and medical necessity. Once approved, MassHealth Standard members pay $1 to $3 per 30-day fill depending on their benefit category.
Is compounded finasteride legal in Massachusetts?
Yes. Licensed 503A compounding pharmacies in Massachusetts may legally compound finasteride for individual patients with a valid prescription. Each preparation must be patient-specific; bulk compounding in anticipation of prescriptions is not permitted under federal law. You can verify a pharmacy's license on the Massachusetts Board of Pharmacy website.
Can I get finasteride via telehealth in Massachusetts?
Yes. Massachusetts law permits telehealth prescribing of finasteride following a synchronous audio-video encounter that meets the standard of care. Finasteride is not a controlled substance, so no in-person visit is required. National platforms such as Hims, Keeps, and Roman all prescribe to Massachusetts residents, as do Massachusetts-licensed independent telehealth clinicians.
Which insurance plans cover finasteride in Massachusetts?
Most Massachusetts commercial plans cover generic finasteride for BPH on Tier 1 or Tier 2 with a $5 to $20 copay. Coverage for the androgenetic alopecia indication varies: some employer plans exclude cosmetic indications. Blue Cross Blue Shield of Massachusetts, Tufts Health Plan, Harvard Pilgrim, and Mass General Brigham Health Plan all cover generic finasteride for BPH. Call your plan's member services line to confirm AGA coverage before filling.
What's the cheapest way to get finasteride in Massachusetts?
For most patients, the cheapest option is generic finasteride 1 mg with a free GoodRx or RxSaver discount card at a high-volume retail pharmacy, typically around $12 per month. Cost Plus Drugs (costplusdrugs.com) and Amazon Pharmacy (for Prime members) may price the drug below $10 per month with free shipping to Massachusetts. MassHealth enrollees with approved prior authorization pay $1 to $3 per fill, which is the lowest cost available.
Are there Massachusetts finasteride discount programs?
Yes. GoodRx, RxSaver, NeedyMeds, and Blink Health offer free discount cards accepted at Massachusetts pharmacies. The Patient Access Network (PAN) Foundation and NeedyMeds have income-based assistance programs for patients below 400% of the federal poverty level. Merck offers a patient assistance program for brand-name Propecia, but the generic's $12 price makes this rarely necessary.
How does the Merck savings card work in Massachusetts?
Merck's savings card for Propecia reduces the out-of-pocket cost for commercially insured patients who meet eligibility criteria. It cannot be used with Medicaid, Medicare, or any government-funded insurance. Given that the generic equivalent costs approximately $12 per month, most Massachusetts patients without insurance find the generic with a GoodRx card more practical than the brand savings card.

References

  1. Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investig Dermatol Symp Proc. 2003;8(1):20-23. https://pubmed.ncbi.nlm.nih.gov/12894991/
  2. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. AccessData FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  3. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  4. MassHealth Drug List and Prior Authorization Criteria. Massachusetts Executive Office of Health and Human Services. https://www.mass.gov/masshealth-drug-list
  5. Moustafa F, Sharma N, Fishman M, et al. Adherence to treatment in patients with alopecia: a systematic review. J Am Acad Dermatol. 2020;82(1):1-10. https://pubmed.ncbi.nlm.nih.gov/31279564/
  6. U.S. Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  7. Caserini M, Radicioni M, Leuratti C, et al. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int J Clin Pharmacol Ther. 2016;54(1):19-27. https://pubmed.ncbi.nlm.nih.gov/26587582/
  8. Massachusetts Division of Insurance. Telehealth coverage requirements under M.G.L. c. 175, s. 47BB. https://www.mass.gov/telehealth
  9. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660
  10. NeedyMeds. Finasteride patient assistance and discount programs. NeedyMeds.org. https://www.needymeds.org
  11. Tosti A, Piraccini BM, Soli M. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia. J Eur Acad Dermatol Venereol. 2001;15(5):418-421. https://pubmed.ncbi.nlm.nih.gov/11763388/
  12. Traish AM, Mulgaonkar A, Giordano N. The dark side of 5alpha-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression. Korean J Urol. 2014;55(6):367-379. https://pubmed.ncbi.nlm.nih.gov/24955224/
  13. Vujovic A, Del Marmol V. The female pattern hair loss: review of etiopathogenesis and diagnosis. Biomed Res Int. 2014;2014:767628. https://pubmed.ncbi.nlm.nih.gov/24812626/
  14. Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5):768-776. https://pubmed.ncbi.nlm.nih.gov/11050580/